What to Expect
Treatment candidacy and consent
Estimated time: 15 minutes
Dr. Orr reviews your migraine history, confirms you meet the criteria for chronic migraine (15 or more headache days per month for at least three months), and discusses the expected benefits, risks, and timeline for response. Most patients require two to three treatment cycles before seeing full benefit.
Injection site preparation
Estimated time: 5 minutes
You are seated upright. The injection sites are identified across the forehead, temples, back of the head, neck, and upper shoulders following the established 31-site injection protocol. No anesthesia is needed.
Botulinum toxin injections
Estimated time: 15 minutes
Dr. Orr administers small doses of botulinum toxin at each of the 31 standardized injection sites using a fine needle. The entire injection process takes approximately 10 to 15 minutes. Most patients describe the injections as brief pinches. Additional sites may be added based on your specific pain pattern.
Post-treatment instructions
Estimated time: 5 minutes
You can return to normal activities immediately. Dr. Orr provides instructions about avoiding rubbing the injection areas and what to expect in the days following treatment. The effect typically takes one to two weeks to develop and lasts approximately 10 to 12 weeks.
Follow-up and re-treatment schedule
Estimated time: 10 minutes
Chemodenervation is repeated every 12 weeks. Dr. Orr monitors your headache frequency and severity at each follow-up and adjusts the injection pattern based on your response. Most patients track progress with a headache diary.
Chemodenervation for Chronic Migraine
Chemodenervation for chronic migraine uses botulinum toxin injections following the PREEMPT protocol — one of the most studied preventive treatments available. At The Neurogenesis Project, Dr. Sean Orr administers chemodenervation as part of a comprehensive neurological approach to reducing headache frequency, severity, and the cumulative disability that chronic migraine imposes.
Available at our St. Marys, Georgia clinic.
What Chemodenervation Is and Why It Works for Migraine
Chemodenervation refers to the injection of botulinum toxin type A (onabotulinumtoxinA, marketed as Botox) into specific muscle groups to block neuromuscular transmission. The FDA approved onabotulinumtoxinA for chronic migraine prevention in 2010, based on the PREEMPT clinical trial program—two large, randomized, double-blind, placebo-controlled trials involving a combined 1,384 patients.
The drug works by cleaving SNARE proteins at the neuromuscular junction, which prevents the release of acetylcholine and temporarily reduces muscle contraction. But the migraine-relevant mechanism goes beyond muscle relaxation. Research published over the past two decades has demonstrated that botulinum toxin also inhibits the release of calcitonin gene-related peptide (CGRP), substance P, and glutamate from sensory nerve terminals in the trigeminal system. These neuropeptides drive the neurogenic inflammation and central sensitization that sustain chronic migraine. By reducing their release at peripheral nerve endings, chemodenervation interrupts the pain signaling cascade before it reaches the brainstem.
Chronic migraine is defined as 15 or more headache days per month for at least three consecutive months, with at least eight of those days meeting criteria for migraine or responding to migraine-specific treatment. This threshold distinguishes chronic migraine from episodic migraine and identifies the population most likely to benefit from chemodenervation. Patients below this threshold are generally managed with other preventive strategies.
The PREEMPT Injection Protocol
The Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) trials established the standardized injection paradigm used in clinical practice today. Aurora et al. (2010, PREEMPT 1, n=679) and Diener et al. (2010, PREEMPT 2, n=705) demonstrated that onabotulinumtoxinA significantly reduced headache days, migraine days, and cumulative headache hours compared to placebo over two treatment cycles. The pooled analysis by Dodick et al. (2010) confirmed these findings across the combined population.
The fixed-site protocol involves 31 injection sites distributed across seven muscle groups: the frontalis, corrugator, procerus, temporalis, occipitalis, cervical paraspinal muscles, and trapezius. Each site receives 5 units, totaling 155 units per session. Dr. Orr may add up to 40 additional units at “follow the pain” sites—areas where the patient reports concentrated or radiating pain that falls outside the fixed protocol map. This individualized approach allows the treatment to account for anatomical variation in pain referral patterns.
Treatment is administered every 12 weeks. The PREEMPT data showed that response rates improved with successive cycles, and most headache specialists evaluate efficacy after two to three full treatment cycles before concluding that a patient is a non-responder. The in-office procedure takes approximately 15 to 20 minutes and requires no sedation, anesthesia, or recovery time.
Clinical Applications
Botulinum toxin chemodenervation has FDA-approved indications and evidence-supported uses across several conditions treated at The Neurogenesis Project.
Chronic Migraine Prevention
The primary FDA-approved indication. The pooled PREEMPT analysis demonstrated a mean reduction of 8.4 headache days per 28-day period in the treatment group, with 47.1% of patients achieving a 50% or greater reduction in headache days by the end of the study. This remains the best-supported use of chemodenervation in headache medicine.
Cervical Dystonia
Cervical dystonia involves involuntary, sustained contraction of neck muscles causing abnormal head posture and pain. OnabotulinumtoxinA is FDA-approved for this indication, and injection into the affected muscles (typically sternocleidomastoid, splenius capitis, and trapezius) reduces muscle overactivity and associated pain. Dr. Orr uses EMG guidance when needed to localize target muscles precisely.
Chronic Tension-Type Headache
While the evidence for tension-type headache is less robust than for chronic migraine, some patients with chronic daily headache that includes both migraine and tension-type features benefit from chemodenervation of the pericranial muscles. Dr. Orr evaluates these cases individually and considers chemodenervation when standard oral prophylactics have been insufficient.
Medication Overuse Headache
Patients with chronic migraine frequently develop medication overuse headache from repeated use of acute treatments. Chemodenervation can serve as a bridge prophylactic during the withdrawal period, providing preventive coverage while the patient reduces or eliminates overused acute medications. This approach helps prevent the rebound cycle that makes withdrawal from analgesics difficult.
How Chemodenervation Fits Into Your Treatment Protocol
At The Neurogenesis Project, chemodenervation is not a standalone therapy. It is one component of a broader, diagnostic-driven protocol that addresses the multiple mechanisms contributing to a patient’s chronic headache burden. Dr. Orr begins with a comprehensive neurological evaluation, headache diary review, and relevant laboratory and imaging studies to characterize each patient’s headache phenotype and identify modifiable contributing factors.
For patients who meet criteria for chronic migraine, chemodenervation addresses the peripheral sensitization component—the overactive nociceptive signaling from trigeminal and cervical nerve terminals. Other elements of the protocol may target acute pain relief (occipital nerve blocks) or metabolic contributors (IV nutrient therapy to correct magnesium, riboflavin, or CoQ10 deficiencies that lower migraine threshold).
Dr. Drew Edwards, our neurocoach, works alongside Dr. Orr to address behavioral and lifestyle factors that influence migraine frequency: sleep architecture, stress physiology, caffeine patterns, and exercise tolerance. Chemodenervation reduces the biological noise sufficiently for patients to engage meaningfully with these behavioral interventions—a combination that tends to produce better sustained outcomes than either approach alone.
The session fee is $175 plus the cost of the medication itself. We work with patients to navigate insurance coverage for the medication component and provide transparent pricing before any treatment begins.
Related Treatments
Chemodenervation is often combined with complementary therapies to address multiple aspects of chronic migraine pathophysiology.
Occipital Nerve Block
Targeted anesthetic injection at the greater and lesser occipital nerves for acute migraine relief and occipital neuralgia. Provides rapid pain reduction that bridges the interval between chemodenervation cycles.
Myers’ Cocktail IV Therapy
Intravenous magnesium, B vitamins, and other micronutrients that address metabolic deficiencies known to lower migraine threshold. Magnesium in particular has well-documented effects on cortical excitability and NMDA receptor function.
Frequently Asked Questions
What is the difference between chemodenervation and cosmetic Botox?+
The drug is the same, but the purpose, injection sites, and doses are different. Cosmetic Botox uses small doses in a few facial muscles. Medical chemodenervation uses 155 units across 31 injection sites in head and neck muscles following a specific protocol for chronic migraine.
Read the full answer
The drug is the same — onabotulinumtoxinA — but the clinical purpose, injection sites, and dosing are different. Cosmetic applications use small doses in a few facial muscles to reduce wrinkles. Chemodenervation for chronic migraine follows the PREEMPT protocol: 155 units across 31 fixed injection sites in seven head and neck muscle groups, with optional additional sites guided by the patient's pain pattern. The mechanism relevant to migraine is not cosmetic muscle relaxation but inhibition of neuropeptide release from sensory nerve terminals.
How many treatments will I need before I see results?+
Treatment cycles happen every 12 weeks. Some patients respond after the first cycle, but the full benefit typically develops after two to three cycles. If there is no meaningful improvement after three cycles, we consider alternative approaches.
Read the full answer
Treatment cycles occur every 12 weeks. The pooled PREEMPT analysis (Dodick et al., 2010) showed that some patients responded within the first cycle, but the full therapeutic benefit typically developed after two to three cycles. Dr. Orr evaluates response using headache diary data and reassesses the treatment plan at each visit. If meaningful improvement has not occurred after three cycles, alternative or adjunctive strategies are considered.
Does chemodenervation hurt?+
The needles are very small (30-gauge). Most patients describe brief pinpricks. The procedure takes about 15 to 20 minutes, and some patients have mild soreness at injection sites for a day or two.
Read the full answer
The injections use a 30-gauge needle, which is among the smallest available. Most patients describe the sensation as brief pinpricks. The procedure takes approximately 15 to 20 minutes. Some patients experience mild soreness at injection sites for a day or two afterward. No anesthesia or sedation is required, and patients drive themselves home.
What are the side effects?+
The most common side effect is mild neck pain, reported by about 6 percent of patients. Injection-site soreness, temporary neck weakness, and eyelid drooping each occur in fewer than 4 percent of patients. Serious side effects are rare.
Read the full answer
The most common side effect in the PREEMPT trials was neck pain, reported by approximately 6% of patients in the treatment group versus 3% in the placebo group. Other reported effects included injection-site pain, muscle weakness in the neck, and eyelid ptosis, each occurring in fewer than 4% of patients. Serious adverse events were rare. Dr. Orr reviews the full risk profile with each patient before treatment and adjusts injection sites or doses if side effects occur.
Is chemodenervation covered by insurance?+
Many insurance plans cover it for chronic migraine after you have tried and failed two or more oral preventive medications. The procedure fee is $175 per session; medication cost is separate and may be partly covered by your pharmacy or medical benefit.
Read the full answer
Many insurance plans cover onabotulinumtoxinA for chronic migraine after documenting failure of two or more oral preventive medications. Coverage criteria vary by payer. The Neurogenesis Project charges a $175 procedure fee per session; the medication cost is separate and may be covered in part or in full by the patient's pharmacy or medical benefit. Our team can help clarify coverage before treatment begins.
Can chemodenervation be combined with other migraine treatments?+
Yes. Dr. Orr often combines chemodenervation with nerve blocks for acute flares and IV magnesium or Myers' Cocktail infusions for nutrient deficiencies that lower your migraine threshold.
Read the full answer
Yes. In clinical practice, chemodenervation is frequently combined with other preventive strategies. At The Neurogenesis Project, Dr. Orr may integrate chemodenervation with occipital nerve blocks for acute flares, IV magnesium or Myers' Cocktail infusions to address nutrient deficiencies that lower migraine threshold. The combination depends on the patient's headache pattern, comorbidities, and response to prior therapies.
Do I need to meet specific criteria for insurance coverage?+
Most plans require 15 or more headache days per month for at least three months, with at least eight meeting migraine criteria, plus documented failure of two or more preventive medications. We are a direct-care practice and do not handle prior authorization, but we provide a superbill you can submit to your plan.
Read the full answer
For Botox for chronic migraine, most plans require 15 or more headache days per month for at least three months, with at least eight meeting migraine criteria, and documentation that two or more classes of preventive medication have failed. For cervical dystonia, documentation requirements differ. As a direct-care practice, we do not bill insurance or handle prior authorization. We provide a detailed superbill and visit records you can submit to your own plan.
How does chemodenervation compare to CGRP inhibitor injections?+
They work through different mechanisms and can be used together. Chemodenervation blocks nerve signaling at 31 injection sites every 12 weeks. CGRP antibodies block a specific pain pathway via a monthly or quarterly self-injection. Many chronic migraine patients benefit from both.
Read the full answer
These work through different mechanisms and can be used together. Chemodenervation blocks neurotransmitter release at peripheral nerve terminals, requiring 31 in-office injections every 12 weeks. CGRP antibodies block the calcitonin gene-related peptide pathway via self-injection monthly or quarterly. Clinical trials show comparable efficacy. The choice depends on insurance coverage, preference, and prior response. Many of our chronic migraine patients benefit from both.
How much does chemodenervation cost without insurance?+
The out-of-pocket cost ranges from $600 to $1,200 depending on the number of injection sites and units needed. We do not bill insurance or obtain prior authorization; we provide a superbill you can submit for possible reimbursement.
Read the full answer
The out-of-pocket cost ranges from $600 to $1,200 depending on the number of injection sites and units required. The chronic migraine protocol involves 155 units across 31 sites. We do not bill insurance or obtain prior authorization; we provide a superbill you can submit for possible out-of-network reimbursement. Our patient coordinator can provide an exact cost estimate and discuss payment options.
Reduce Your Migraine Burden
If you experience 15 or more headache days per month, chemodenervation may be an appropriate component of your treatment plan. Schedule a consultation with Dr. Orr to review your headache history, discuss the evidence, and determine whether the PREEMPT protocol is right for you.